cytarabine has been researched along with thiourea in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lönn, S; Lönn, U | 1 |
| Drewinko, B; Vadi, H | 1 |
| Angeli, V; Croxford, JL; Gasser, S; Khan, MK; Tan, KW; Tang, ML | 1 |
3 other study(ies) available for cytarabine and thiourea
| Article | Year |
|---|---|
Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
Topics: Cell Line; Cisplatin; Cytarabine; DNA Damage; DNA Replication; DNA, Neoplasm; Endonucleases; Humans; Isomerism; Kinetics; Melanoma; Metronidazole; Organoplatinum Compounds; Single-Strand Specific DNA and RNA Endonucleases; Thiourea | 1987 |
Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Topics: Cell Line; Cell Survival; Cell-Free System; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; Cytarabine; DNA; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Kinetics; Thiourea | 1986 |
The DNA damage response induces antigen presenting cell-like functions in fibroblasts.
Topics: Animals; Antigen-Presenting Cells; Antigens, Differentiation, T-Lymphocyte; Ataxia Telangiectasia Mutated Proteins; Benzeneacetamides; Blotting, Western; Bone Marrow Cells; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Cytarabine; Dendritic Cells; DNA Damage; Fibroblasts; Flow Cytometry; Intercellular Adhesion Molecule-1; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Ovalbumin; Thiourea | 2014 |